This column, as an extended series of notes on portfolio management and dividends, is meant to offer thoughtful analysis and ideas. Given its subject matter, racing pulses are an unlikely by-product.
But for those readers hungry for drama, last week finished with what will have to pass for a cliffhanger. To recap: defying institutional wisdom and spasmodic gut instinct, your columnist vowed to live dangerously with that unloved stock market phenom, Plus500 (PLUS). The question – to be resolved here today – was how to fund the share purchase.